<DOC>
	<DOCNO>NCT01489748</DOCNO>
	<brief_summary>This study primarily design evaluate impact AVONEX PEN autoinjector work capacity participant multiple sclerosis ( MS ) start device . This study also evaluate secondary endpoint various patient-reported outcome short-term ( 1 month ) , include adherence , treatment satisfaction convenience , long-term ( 12 24 month ) , include adherence , persistence , quality life ( QOL ) , treatment satisfaction convenience . It also assess health resource utilization MS participant start AVONEX PEN autoinjector , well overall safety/tolerability , correlate secondary outcome primary ( i.e. , work capacity ) .</brief_summary>
	<brief_title>Canadian Avonex PEN Productivity Study</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Interferon beta-1a</mesh_term>
	<criteria>Key Must prescribe AVONEX PEN per local labeling ( Product Monograph ) enrol MS Alliance ( MSA ) program If switch another DMT , must DMT least 6 month Last DMT subject switch must injectable Must able physically demonstrate use AVONEX PEN autoinjector device able selfadminister injection Must give write informed consent . If require local law , candidate must also authorize release use protect health information ( PHI ) Must able understand comply protocol Key Female subject consider become pregnant study currently pregnant breastfeed Current enrollment investigational study involve drug , biologic nondrug therapy Participation clinical study within past 6 month Treatment immunosuppressive regimen ( e.g . cyclophosphamide , azathioprine , methotrexate mitoxantrone ) intravenous immunoglobulin ( IVIg ) last 6 month The recent DMT subject switch noninjectable ( i.e. , oral ) Other unspecified reason , opinion Investigator Sponsor , make subject unsuitable enrollment NOTE : Other protocol define Inclusion/Exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>